SCHEMBL10071260

SCHEMBL10071260

CC1(NC(=O)c2ccccc2)CC1CCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.46
HPGD P15428 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC1 Q13547 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CNR2 P34972 1/20 0.41
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
TP53 P04637 1/20 0.40
KCNH2 Q12809 1/20 0.40
P2RX7 Q99572 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX12 P18054 1/20 0.40
EZH2 Q15910 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071259 0.83 CYP3A4 (0.46) FAAHMAPK1CYP2C19HDAC1HDAC8
SCHEMBL544830 0.75 MAPK1 (0.44) FAAHHPGDNPC1RAB9AMAPK1
SCHEMBL668810 0.73 P2RX7 (0.50) NPC1RAB9AHDAC1HDAC8TP53
SCHEMBL10071248 0.72 MAPK1 (0.63) FAAHMAPK1CYP2C19HDAC1KDM4E
SCHEMBL1740252 0.67 MAPK1 (0.60) FAAHMAPK1CYP2C19KDM4EMEN1
SCHEMBL12987195 0.67 FAAH (0.51) FAAHHPGDMAPK1CYP2C19HDAC1
SCHEMBL10073915 0.66 FFAR4 (0.41) KMT2A
SCHEMBL8738670 0.65 EZH2 (0.74) MEN1KMT2AEZH2
SCHEMBL20006341 0.65 FFAR4 (0.43) KMT2AALDH1A1
SCHEMBL668935 0.65 SLC1A2 (0.42) HPGDNPC1RAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110699-B2 Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-07 US disclosed
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates PPOX, IDH3A, HMOX2 FAAH 2275/4885HPGD 154/4885NPC1 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.